SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal Cancer

NCT04417699 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: TAS 102
DRUG: Oxaliplatin

Sponsor

Providence Health & Services

Collaborators

[object Object]